ArticleInternational journal of molecular sciences2021

Empagliflozin Improves Metabolic and Hepatic Outcomes in a Non-Diabetic Obese Biopsy-Proven Mouse Model of Advanced NASH.

Nikolaos Perakakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.